Evaxion Biotech A/S (NASDAQ:EVAX) and Pantherna Therapeutics GmbH announced a preclinical proof of concept for combining the two companies key technologies. The…
Gainers
Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares rose 105% to $0.41 in pre-market trading after the company requested to withdraw its registration on Form S-1 and said it does not intend to pursue the contemplated public offering.
Evaxion Biotech A/S (NASDAQ:EVAX) has announced interim safety and immunogenicity data from the Phase 1/2a first-in-human study of its DNA-based cancer…
Evaxion Biotech A/S (NASDAQ:EVAX) ("Evaxion" or the "Company"), a clinical-stage biotechnology company specializing in the development of AI-driven immunotherapies, today announced promising clinical
Gainers
Benitec Biopharma (NASDAQ:BNTC) shares increased by 9.8% to $0.35 during Tuesday's after-market session. The company's market cap stands at $9.0 million.